Global Circadian Rhythm Sleep Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Circadian Rhythm Sleep Treatment market size was valued at US$ 789 million in 2024 and is forecast to a readjusted size of USD 1337 million by 2031 with a CAGR of 7.9% during review period.

Circadian rhythm disorders are disruptions in a patient's internal clock that regulates a variety of biological processes, which makes it difficult to follow normal sleep patterns. The circadian rhythm disorders include: Delayed sleep-wake phase, Advanced sleep-wake phase, Irregular sleep-wake rhythm, Non-24-hour sleep-wake rhythm, Shift work, Jet lag. The most common treatments for circadian rhythm disorders are healthy lifestyle changes, bright light therapy, and melatonin. It is aim to reset people's sleep-wake rhythm to align with the environment.

The global circadian rhythm sleep treatment market is set for continued growth driven by increased awareness, advancements in treatment options, and technological innovations. The emphasis on personalized medicine, improved diagnostic tools, and a growing focus on sleep health and wellness are key factors contributing to market expansion. However, challenges such as regional disparities in awareness and the cost of advanced treatments remain. Ongoing research and development will play a crucial role in shaping the future of the market.Global key players of circadian rhythm sleep treatment include Takeda Pharmaceutical, NBTY, Nature Made (Pharmavite) and Vicks (Procter & Gamble), etc. The top four players hold a share over 40%. In terms of product type, drug therapy is the largest segment, occupied for a share of approximately 80%, and in terms of application, delayed sleep phase syndrome has a share about 50%.

This report is a detailed and comprehensive analysis for global Circadian Rhythm Sleep Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Circadian Rhythm Sleep Treatment market size and forecasts, in consumption value ($ Million), 2020-2031

Global Circadian Rhythm Sleep Treatment market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Circadian Rhythm Sleep Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Circadian Rhythm Sleep Treatment market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Circadian Rhythm Sleep Treatment

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Circadian Rhythm Sleep Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Koninklijke Philips, Luminette, Sleepace, PEGASI, Teva Pharmaceuticals, Takeda Pharmaceutical, NBTY, Vicks (Procter & Gamble), Natrol, Nature Made (Pharmavite), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Circadian Rhythm Sleep Treatment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Drug Therapy
Light Therapy

Market segment by Application
Delayed Sleep Phase Syndrome (DSPS)
Advanced Sleep Phase Syndrome (ASPS)
Irregular Sleep-Wake Disorder (ISWD)
Others

Market segment by players, this report covers
Koninklijke Philips
Luminette
Sleepace
PEGASI
Teva Pharmaceuticals
Takeda Pharmaceutical
NBTY
Vicks (Procter & Gamble)
Natrol
Nature Made (Pharmavite)
Jameison
GNC
By-Health

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Circadian Rhythm Sleep Treatment product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Circadian Rhythm Sleep Treatment, with revenue, gross margin, and global market share of Circadian Rhythm Sleep Treatment from 2020 to 2025.

Chapter 3, the Circadian Rhythm Sleep Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Circadian Rhythm Sleep Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Circadian Rhythm Sleep Treatment.

Chapter 13, to describe Circadian Rhythm Sleep Treatment research findings and conclusion.